1. Home
  2. Medical Devices & Consumables
  3. Global Market Analysis Of Cardiac Biomarkers Market By Type, By Application, By End User, And By Region (global Market Forecast To 2027)

Global Market Analysis Of Cardiac Biomarkers Market By Type, By Application, By End User, And By Region (global Market Forecast To 2027)

Publication Month: Jun 2020 | No. of Pages: 122 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Definition

The Global Cardiac Biomarkers market is estimated at $ 7.5 billion in 2019, and expected to reach $ 19.24 billion by 2027, with a CAGR of 12.5% from 2020 to 2027.

 

When the heart is damaged or stressed, various substances are released into the blood, and this substance is known as biomarkers.  And these biomarkers are measured to diagnose various heart diseases and early prediction of cardiac related diseases.

 

Market Dynamics

The Global Cardiac Biomarkers market is primarily driven by factors such as the growing occurrences of cardiovascular diseases; growing demand for cardiac biomarkers; growing cases of acute coronary syndrome (ACS); growing technological innovations in development of the cardiac biomarkers; growing demand for point of care testing kits; growing focus on research and development; growing importance of cardiac biomarker for quick and accurate detection of cardiac failures; growing demand for cardiovascular diagnosis; changing lifestyle and unhealthy eating habits; are some of the market dynamics.

Market Segmentation

The Global Cardiac Biomarkers Market is mainly classified based on Type, Application, End User, and Region.

  • Based on Type, the market is further segmented into Troponin, Natriuretic Peptides - BNP and NT-pro BNP, Myocardial Muscle Creatinine Kinase (CK-MB), Myoglobin, Ischemia Modified Albumin (IMA) and Others

  • Based on Application, the market is further segmented into Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Myocardial Infarction, and Others

  • Based on End User, the market is further segmented into Point of Care Testing, Laboratory Testing, and Other Users

 

Regional Analysis

Based on geography, the Global Cardiac Biomarkers market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa                                                                                       

                                      

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

 

Competitive Landscape                      

Global Cardiac Biomarkers Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global Cardiac Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2019-2027, this study provides the Global Cardiac Biomarkers sales, revenue and market share for each player covered in this report.

                                                                                   

The major players covered in Global Cardiac Biomarkers are Beckman Coulter Inc., Abbott Laboratories, Alere Inc., Roche Diagnostics Corporation, Siemens Healthcare GmbH, BG Medicines, Becton (Dickinson and Company), Thermo Fisher Scientific Inc., BioMerieux SA, Olympus Corporation, Johnson and Johnson, PerkinElmer Inc., Tosoh Corporation, and other prominent players.

 

 

 

 

 

Cardiac Biomarkers Market Key Segments:

By Type              

  • Troponin

  • Natriuretic Peptides - BNP and NT-pro BNP

  • Myocardial Muscle Creatinine Kinase (CK-MB)

  • Myoglobin

  • Ischemia Modified Albumin (IMA)

  • Others

By Application    

  • Congestive Heart Failure

  • Acute Coronary Syndrome

  • Atherosclerosis

  • Myocardial Infarction

  • Others

By End User

  • Point of Care Testing

  • Laboratory Testing

  • Other Users

By Region              

  • North America

  • The U.S.A

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • Italy

  • Rest of Europe

  • Asia Pacific

  • India

  • China

  • Japan

  • South Korea

  • Rest of Asia Pacific

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • GCC Countries

  • Egypt

  • South Africa

Rest of Middle East & Africa

Table of Content

 

1 Market Overview

1.1 Cardiac Biomarkers Introduction
1.2 Market Analysis by Type

1.2.1 Overview: Global Cardiac Biomarkers Revenue by Type: 2019 VS 2021 VS 2027
1.2.2 Troponin

1.2.3 Natriuretic Peptides – BNP and NT – Pro BNP

1.2.4 Myocardial Muscle Creatinine Kinase (CK-MB)

1.2.5 Myoglobin

1.2.6 Ischemia Modified Albumin (IMA)

1.2.7 Others

1.3 Market Analysis by Application 1.3.1 Overview: Global Cardiac Biomarkers Revenue by Application: 2019 VS 2021 VS 2027
1.3.2 Congestive Heart Failure

1.3.3 Acute Coronary Syndrome 1.3.4 Atherosclerosis

1.3.5 Myocardial Infarction

1.3.6 Others

1.4 Market Analysis by End User

1.4.1 Overview: Global Cardiac Biomarkers Revenue by End User: 2019 VS 2021 VS 2027
1.4.2 Point of Care Testing

1.4.3 Laboratory Testing

1.4.4 Other Users

1.5 Overview of Global Cardiac Biomarkers Market
1.5.1 Global Cardiac Biomarkers Market Status and Outlook (2019-2027)
1.5.2 North America (United States, Canada and Mexico)
1.5.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.5.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.5.5 South America, Middle East & Africa
1.6 Market Dynamics
1.6.1 Market Opportunities
1.6.2 Market Risk 1.6.3 Market Driving Force
2 Manufacturers Profiles
2.1 Beckman Coulter Inc.
2.1.1 Beckman Coulter Inc. Details
2.1.2 Beckman Coulter Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Beckman Coulter Inc. SWOT Analysis
2.1.4 Beckman Coulter Inc. Product and Services
2.1.5 Beckman Coulter Inc. Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Abbott Laboratories SWOT Analysis
2.2.4 Abbott Laboratories Product and Services
2.2.5 Abbott Laboratories Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.3 Alere Inc.
2.3.1 Alere Inc. Details
2.3.2 Alere Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Alere Inc. SWOT Analysis
2.3.4 Alere Inc. Product and Services
2.3.5 Alere Inc. Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.4 Siemens Healthcare GmbH
2.4.1 Siemens Healthcare GmbH Details
2.4.2 Siemens Healthcare GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Siemens Healthcare GmbH SWOT Analysis
2.4.4 Siemens Healthcare GmbH Product and Services
2.4.5 Siemens Healthcare GmbH Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.5 BG Medicines
2.5.1 BG Medicines Details
2.5.2 BG Medicines Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 BG Medicines SWOT Analysis
2.5.4 BG Medicines on Product and Services
2.5.5 BG Medicines Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.6 Becton (Dickinson and Company)
2.6.1 Becton (Dickinson and Company) Details
2.6.2 Becton (Dickinson and Company) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Becton (Dickinson and Company) SWOT Analysis
2.6.4 Becton (Dickinson and Company) Product and Services
2.6.5 Becton (Dickinson and Company) Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.7 Thermo Fisher Scientific Inc.
2.7.1 Thermo Fisher Scientific Inc. Details
2.7.2 Thermo Fisher Scientific Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Thermo Fisher Scientific Inc. SWOT Analysis
2.7.4 Thermo Fisher Scientific Inc. Product and Services
2.7.5 Thermo Fisher Scientific Inc. Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.8 BioMerieux SA
2.8.1 BioMerieux SA Details
2.8.2 BioMerieux SA Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BioMerieux SA SWOT Analysis
2.8.4 BioMerieux SA Product and Services
2.8.5 BioMerieux SA Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.9 Olympus Corporation
2.9.1 Olympus Corporation Details
2.9.2 Olympus Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Olympus Corporation SWOT Analysis
2.9.4 Olympus Corporation Product & Services
2.9.5 Olympus Corporation Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.10 Roche Diagnostics Corporation
2.10.1 Roche Diagnostics Corporation Details
2.10.2 Roche Diagnostics Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Roche Diagnostics Corporation SWOT Analysis
2.10.4 Roche Diagnostics Corporation Product & Services
2.10.5 Roche Diagnostics Corporation Cardiac Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.11 Other Players

3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cardiac Biomarkers Sales and Market Share by Manufacturer (2019-2020)
3.2 Global Cardiac Biomarkers Revenue and Market Share by Manufacturer (2019-2020)
3.3 Market Concentration Rate
3.3.1 Top 3 Cardiac Biomarkers Manufacturer Market Share in 2019 & 2020
3.3.2 Top 6 Cardiac Biomarkers Manufacturer Market Share in 2019 & 2020
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cardiac Biomarkers Sales, Revenue and Market Share by Regions
4.1.1 Global Cardiac Biomarkers Sales and Market Share by Regions (2019-2020)
4.1.2 Global Cardiac Biomarkers Revenue and Market Share by Regions (2019-2020)
4.2 North America Cardiac Biomarkers Sales and Growth Rate (2019-2020)
4.3 Europe Cardiac Biomarkers Sales and Growth Rate (2019-2020)
4.4 Asia-Pacific Cardiac Biomarkers Sales and Growth Rate (2019-2020)
4.5 South America Cardiac Biomarkers Sales and Growth Rate (2019-2020)
4.6 Middle East and Africa Cardiac Biomarkers Sales and Growth Rate (2019-2020)
5 North America by Country
5.1 North America Cardiac Biomarkers Sales, Revenue and Market Share by Country
5.1.1 North America Cardiac Biomarkers Sales and Market Share by Country (2019-2020)
5.1.2 North America Cardiac Biomarkers Revenue and Market Share by Country (2019-2020)
5.2 United States Cardiac Biomarkers Sales and Growth Rate (2019-2020)
5.3 Canada Cardiac Biomarkers Sales and Growth Rate (2019-2020)
5.4 Mexico Cardiac Biomarkers Sales and Growth Rate (2019-2020)
6 Europe by Country
6.1 Europe Cardiac Biomarkers Sales, Revenue and Market Share by Country
6.1.1 Europe Cardiac Biomarkers Sales and Market Share by Country (2019-2020)
6.1.2 Europe Cardiac Biomarkers Revenue and Market Share by Country (2019-2020)
6.2 Germany Cardiac Biomarkers Sales and Growth Rate (2019-2020)
6.3 UK Cardiac Biomarkers Sales and Growth Rate (2019-2020)
6.4 France Cardiac Biomarkers Sales and Growth Rate (2019-2020)
6.5 Russia Cardiac Biomarkers Sales and Growth Rate (2019-2020)
6.6 Italy Cardiac Biomarkers Sales and Growth Rate (2019-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cardiac Biomarkers Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cardiac Biomarkers Sales and Market Share by Regions (2019-2020)
7.1.2 Asia-Pacific Cardiac Biomarkers Revenue and Market Share by Regions (2019-2020)
7.2 China Cardiac Biomarkers Sales and Growth Rate (2019-2020)
7.3 Japan Cardiac Biomarkers Sales and Growth Rate (2019-2020)
7.4 Korea Cardiac Biomarkers Sales and Growth Rate (2019-2020)
7.5 India Cardiac Biomarkers Sales and Growth Rate (2019-2020)
7.6 Southeast Asia Cardiac Biomarkers Sales and Growth Rate (2019-2020)
7.7 Australia Cardiac Biomarkers Sales and Growth Rate (2019-2020)
8 South America by Country
8.1 South America Cardiac Biomarkers Sales, Revenue and Market Share by Country
8.1.1 South America Cardiac Biomarkers Sales and Market Share by Country (2019-2020)
8.1.2 South America Cardiac Biomarkers Revenue and Market Share by Country (2019-2020)
8.2 Brazil Cardiac Biomarkers Sales and Growth Rate (2019-2020)
8.3 Argentina Cardiac Biomarkers Sales and Growth Rate (2019-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cardiac Biomarkers Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cardiac Biomarkers Sales and Market Share by Country (2019-2020)
9.1.2 Middle East & Africa Cardiac Biomarkers Revenue and Market Share by Country (2019-2020)
9.2 Saudi Arabia Cardiac Biomarkers Sales and Growth Rate (2019-2020)
9.3 Turkey Cardiac Biomarkers Sales and Growth Rate (2019-2020)
9.4 Egypt Cardiac Biomarkers Sales and Growth Rate (2019-2020)
9.5 South Africa Cardiac Biomarkers Sales and Growth Rate (2019-2020)
10 Global Cardiac Biomarkers Market Segment by Type
10.1 Global Cardiac Biomarkers Sales Market Share by Type (2019-2020)
10.2 Global Cardiac Biomarkers Revenue Market Share by Type (2019-2020)
10.3 Global Cardiac Biomarkers Price by Type (2019-2020)

11 Global Cardiac Biomarkers Market Segment by Application
11.1 Global Cardiac Biomarkers Sales Market Share by Application (2019-2020)
11.2 Global Cardiac Biomarkers Revenue Market Share by Application (2019-2020)
11.3 Global Cardiac Biomarkers Price by Application (2019-2020)

12 Global Cardiac Biomarkers Market Segment by End User
12.1 Global Cardiac Biomarkers Sales Market Share by End User (2019-2020)
12.2 Global Cardiac Biomarkers Revenue Market Share by End User (2019-2020)
12.3 Global Cardiac Biomarkers Price by End User (2019-2020)

13 Market Forecast
13.1 Global Cardiac Biomarkers Sales, Revenue and Growth Rate (2021-2027)
13.2 Cardiac Biomarkers Market Forecast by Regions (2021-2027)
13.2.1 North America Cardiac Biomarkers Market Forecast (2021-2027)
13.2.2 Europe Cardiac Biomarkers Market Forecast (2021-2027)
13.2.3 Asia-Pacific Cardiac Biomarkers Market Forecast (2021-2027)
13.2.4 South America Cardiac Biomarkers Market Forecast (2021-2027)
13.2.5 Middle East & Africa Cardiac Biomarkers Market Forecast (2021-2027)
13.3 Cardiac Biomarkers Market Forecast by Type (2021-2027)
13.3.1 Global Cardiac Biomarkers Sales Forecast by Type (2021-2027)
13.3.2 Global Cardiac Biomarkers Market Share Forecast by Type (2021-2027)
13.4 Cardiac Biomarkers Market Forecast by Application (2021-2027)
13.4.1 Global Cardiac Biomarkers Sales Forecast by Application (2021-2027)
13.4.2 Global Cardiac Biomarkers Market Share Forecast by Application (2021-2027)

 13.5 Cardiac Biomarkers Market Forecast by End User (2021-2027)
13.5.1 Global Cardiac Biomarkers Sales Forecast by End User (2021-2027)
13.5.2 Global Cardiac Biomarkers Market Share Forecast by End User (2021-2027) .

14 Sales Channel, Distributors, Traders and Dealers
14.1 Sales Channel
14.1.1 Direct Marketing
14.1.2 Indirect Marketing
14.2 Distributors, Traders and Dealers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Data Source
16.3 Disclaimer
16.4 About Us

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets